Therapy of acute myocardial infarction, impact of clinical trials on clinical practice: The MITRA pilot phase;Fruhbehandlung des akuten Myokardinfarktes: Umsetzung von Therapierichtlinien in den klinischen Alltag, MITRA-Pilotphase

Zeitschrift fur Kardiologie

Volumn 86, Issue 4, 1997, Pages 273-283

  Schuster, S ^a   Koch, A ^b   Burczyk, U ^b   Schiele, R ^b   Wagner, S ^b   Zahn, R ^b   Glunz, H G ^b   Heinrich, F ^b   Stuby, K ^b   Berg, G ^b   Voigtlander T ^b   Gieseler, U ^b   Jakob, M ^b   Hauptmann, P ^b   Senges, J ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b NONE

Author keywords

ACE inhibitor; betablocker; myocardial infarction; therapy of myocardial infarction; thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; EMERGENCY; FEMALE; FIBRINOLYTIC THERAPY; GERMANY; HEALTH CARE QUALITY; MALE; MIDDLE AGED; PILOT STUDY; PRACTICE GUIDELINE; PROGNOSIS; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; EMERGENCIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0030611969     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050059     Document Type: Article

References (33)

1. ISIS-2 Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17.187 cases of suspected acute myocardial infarction. Lancet 2:349-360
2. GISSI I (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1:397-401
3. Fibrinolytic therapy trialists' (FTT) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343:331-333
4. Late Study Group (1993) Late assessment of thrombolytic efficacy study with altepluse 6-24 hours after onset of acute myocardial infarction. Lancet 342:759-766
5. Paolasso E (1992) Randomised trial of late thrombolysis in acute myocardial infarction: EMERAS. In: Sleight P. Tuvazzi T (eds) The Major Clinical Trials on Thrombolysis for Acute Myocardial Infarction. Raven Press, Ltd. New York
6. ISIS-4 (1993) An randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patients with suspected acute myocardial infarction. Lancet 345: 669-85
7. GISSI 3 (1994) Effects of lisinopril and transdermal glyceryl trinitrate single and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343:1115-22
8. Lamas GA, Pfeffer MA, Hamm P, Wertheimer J, Rouleau JL, Braunwald E, for the SAVE investigators (1993) Do the results of randomised clinical trials of cardiovascular drugs influence medical practice? N Engl J Med 327:241-247
9. Ketley D, Woods KL (1993) Impact of clinical trials on clinical practice: example of thrombolysis of acute myocardial infarction. Lancet 342:891-894
10. Schiele R, Rustige J, Burczyk U, Koch A, Döring W, Neuhaus KL, Senges J (1994) Das 60-Minuten-Herzinfarktprojekt: Einfluß relativer Kontraindikationen auf die Lyse in Deutschland. Z Kardiol 83:106 Suppl 1
11. Schuster S, Burczyk U, Wagner S, Senges J (1995) Initialtherupie beim akuten Myokardinfarkt. Wie häufig können adjuvante Therapeutika zur Lyse gegeben werden? Praktikabilitäl und Sicherheit. Z Kardiol 84:72 (Abstract)
12. Grines CL, DeMaria AN (1990) Optimal utilization of thrombolytic therapy of acute myocardial infarction: concepts and controversies. J Am Coll Cardiol 16: 223-231
13. Collins R, for the ISIS Collaborative Group (1991) Optimising thrombolytic therapy of acute myocardial infarction: age is not a contraindication. Circulation 84 (suppl II): II-230
14. Schiele R, Rustige J, Burczyk U, Koch A, Tebbe U, Senges J (1995) Thrombolysis after resuscitation in acute myocardial infarction. Eurp Heart J 6 (suppl): 10
15. Jagger JD, Murray RG, Davies MK, Little WA, Flint EJ (1987) Eligibility for thrombolytic therapy in acute myocardial infarction. Lancet 1:34-35
16. Doorey AJ, Michelson EL, Topol EJ (1992) Thrombolytic therapy of acute myocardial infarction: keeping the unfulfilled promises. JAMA 268:3108-3114
17. Yusuf S, Sleight P, Held P, McMahon S (1990) Routine medical management of acute myocardial infarction: lessens from overviews of recent randomised controlled trials. Circulation 82 (suppl II):II-117-II-124
18. Löwel H, Lewis M, Keil U, Hörmann A, Bolte HD, Willich S, Gostomzyk J (1995) Zeitlicher Trend von Herzinfarktmorbidität, -mortalität, 28-Tage-Letalität und medizinischer Versorgung. Z Kardiol 84: 596-605
19. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambtrew CT, Rubinson RM, Tiefenbrunn AJ, Weaver WD (1994) Treatment of myocardial infarction in the United States (1990 to 1993). Observation from the national registry of myocardial infarction. Circulation 90: 2103-2114
20. Sju AL, MC Glynn EA, Mortgenstern H, et al (1992) Choosing quality of care measures based on the expected impact of improved care on health. Health Serv Res 27:619-50
21. Brand DA, Newcomer LN, Freiburger A, Tian H (1995) Cardiologists' practices compared with practice guidelines: Use of beta-blockade after myocardial infarction. J Am Coll Cardiol 26:1432-36
22. Simoons ML (1994) Myocardial infarction: ACE inhibitors for all for ever? Lancet 344:297-298
23. Pfeffer MA (1995) ACE inhibitors in acute myocardial infarction. N Engl J Med 332: 118-120
24. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni GT (1995) ACE inhibitors use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation 92:3132-3137
25. The GUSTO investigators (1993) An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:637-82
26. The MIAMI Trial Research Group (1985) Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Mean J 6: 199-226
27. Löwel H, Lewis M, Hormann A (1988) Prognostische Bedeutung der Prähospitalphase beim akuten Myocardinfarkt. Ergebnisse des Augsburger Herzinfarktregisters 1985-1988
28. Jenkins JS, Flaker, Nolte B, Price LA, Morris D, Kurz J, Petroski GF (1994) Causes of higher in-hospital mortality in woman than in men after acute myocardial infarction. Am J Cardiol 73:319-322
29. Klein H, Hengstenberg C, Peuckert M, Jürgens R (1993) Comparison of death rates from acute myocardial infarction in a single hospital in two different periods (1977-1978 vs 1988-1989). Am J Cardiol 71: 518-523
30. Dellborg M, Eriksson P, Riha M, Swedberg K (1994) Declining hospital mortality in acute myocardial infarction. Eur Heart J 15:5-9
31. LeFeuvre CA, Conolly SJ, Cairns JA (1994) Comparison of mortality from acute myocardial infarction between 1980, 1987 and 1992 in a geographical-defined stable population. Circulation 88:no 4 abstract 2735
32. ISIS-3 (1992) a randomised comparison of streptokinase vs tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 339:753-770
33. The international study group (1990) Inhospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet 336:71-75